Line 33: | Line 33: | ||
<!---------------------------Top image on page------------------------------------------> | <!---------------------------Top image on page------------------------------------------> | ||
− | + | <div class="imagearea"> | |
− | + | <img src="https://static.igem.org/mediawiki/2016/b/b9/T--Virginia--References_header.png"> | |
</div> | </div> | ||
Revision as of 23:03, 16 October 2016
![](https://static.igem.org/mediawiki/2016/b/b9/T--Virginia--References_header.png)
- Mandell, Daniel J., Marc J. Lajoie, Michael T. Mee, Ryo Takeuchi, Gleb Kuznetsov, Julie E. Norville, Christopher J. Gregg, Barry L. Stoddard, and George M. Church. "Corrigendum: Biocontainment of Genetically Modified Organisms by Synthetic Protein Design." Nature 527.7577 (2015): 264. Web.
- Nanduri, V.B., Goldberg, S., Johnston, R., and Patel, R.N. (2004). Cloning and expression of a novel enantioselective N-carbobenzyloxy-cleaving enzyme. Enzyme and Microbial Technology 34, 304–312.
- Shlomiya Bar-Yam, Jennifer Byers-Corbin, Rocco Casagrande, Florentine Eichler, Allen Lin, Martin Oesterreicher, Pernilla Regardh, R. Donald Turlington, and Kenneth A. Oye (2012). The Regulation of Synthetic Biology (SynBERC).
- Department of Health and Human Services (2016). NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (National Institute of Health).
- Sarah R. Carter, Ph.D., Michael Rodemeyer, J.D., Michele S. Garfinkel, Ph.D., and Robert M. Friedman, Ph.D. (2014). Synthetic Biology and the US Biotechnology Regulatory System: Challenges and Option (J. Craig Venter Institute).